Browsing by Subject "topiramate"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Linking topiramate exposure to changes in electrophysiological activity and behavioral deficits through quantitative pharmacological modeling
    (2019-05) Callisto, Samuel
    Topiramate is a broad-spectrum anti-epileptic drug used to treat a variety of conditions, including epilepsy, migraine, substance abuse, mood, and eating disorders. We investigated the effects of topiramate on the working memory system using population pharmacokinetic-pharmacodynamic modeling and unsupervised machine learning approaches. Working memory is the capacity-limited neurocognitive system responsible for simultaneous maintenance and manipulation of information in order to achieve a goal. Behavioral and electrophysiological indices of working memory function were measured using data collected during a double-blind, placebo-controlled crossover study in healthy volunteers. Subjects completed a Sternberg working memory task, during which accuracy and reaction time were measured, while subjects’ EEG was recorded. A pharmacokinetic-pharmacodynamic model was constructed which demonstrated that accuracy decreased linearly as a function of plasma concentration, and that the magnitude of individual deficits was predicted by working memory capacity. A separate pharmacokinetic-pharmacodynamic model was developed which showed that spectral power in the theta frequency band (4-8 Hz) recorded during the retention phase of the Sternberg task increased as a function of plasma concentration. Furthermore, a mixture model identified two subpopulations with differential sensitivity in topiramate-induced theta reactivity. In the subpopulation defined by lower reactivity, reaction times were 20% slower than in the high theta reactivity subpopulation. Principal component regression was used to quantify the relationship between changes in multiple measures of electrophysiological activity and behavioral deficits. Theta power during retention was found to be the best predictor of topiramate-related behavioral deficits. Performance on another working memory task, Digit Span Forward, was also predicted by theta power during retention, as well as alpha (8-12 Hz) power during encoding and retrieval stages. In conclusion, two treatment-independent factors that predict differences in behavioral and electrophysiological responses to topiramate administration were identified: working memory capacity and theta reactivity. Future research will be needed to determine the utility of these demographic factors in predicting risk of cognitive side effects in patients eligible for treatment with topiramate.
  • Thumbnail Image
    Item
    Topiramate Induced Alteration in Frontal Lobe eLORETA-ICA Resting State Network Activity is Associated with Baseline Semantic Fluency Performance
    (2020-12) LUISI, SCOTT
    Topiramate (TPM) is associated with a high rate of intolerable cognitive side effects that remain poorly understood and difficult to predict clinically. To investigate the underlying brain functions affected by TPM we applied eLORETA-ICA to resting state EEG data from 27 healthy subjects from both no-drug baseline and TPM study visits. Resting state independent component networks (ICs) were visualized and TPM related changes in network activity were identified with nonparametric paired permutation tests. Regression was then performed to associate baseline IC activity to changes in performance on neuropsychological test measures. We identified a subgroup of subjects defined by high baseline semantic fluency (SF) in whom: 1.TPM induced significant changes in prefrontal cortex activity in the high beta and gamma frequency ranges, and 2.baseline IC activity was associated with subsequent worsening in SF performance. This research shows eLORETA-ICA is a viable method of identifying drug-related changes in resting state network activity.